NYMOX PHARMACEUTICAL CORPORATION Profit Loss Before Tax
NYMOX PHARMACEUTICAL CORPORATION (NYMXF) reported Profit Loss Before Tax of -$4.49 million for the 12-month period ending 2024-12-31, per its 20-F filed 2025-06-03.
Financial Statements › Notes
ifrs-full:ProfitLossBeforeTax · last filed 2025-06-03
- NYMOX PHARMACEUTICAL CORPORATION profit loss before tax for the quarter ending 2024-12-31 was -$857.00K.
- NYMOX PHARMACEUTICAL CORPORATION profit loss before tax for the quarter ending 2024-09-30 was -$716.00K.
- NYMOX PHARMACEUTICAL CORPORATION profit loss before tax for the quarter ending 2023-12-31 was -$5.31M.
- NYMOX PHARMACEUTICAL CORPORATION profit loss before tax for the quarter ending 2023-09-30 was -$1.04M.
| Period end | Profit Loss Before Tax 3 month | Profit Loss Before Tax 6 month | Profit Loss Before Tax 9 month | Profit Loss Before Tax 12 month | Profit Loss Before Tax 12 month as first filed |
|---|---|---|---|---|---|
| 2024-12-31 | -$857.00K derived: 20-F 12 month − 6-K 9 month · filed 2025-06-03 | -$1.57M derived: sum of 2 quarters · filed 2025-06-03 | -$4.49M 20-F · filed 2025-06-03 | ||
| 2024-09-30 | -$716.00K 6-K · filed 2025-01-02 | -$3.63M 6-K · filed 2025-01-02 | |||
| 2023-12-31 | -$5.31M derived: 20-F 12 month − 6-K 9 month · filed 2025-06-03 | -$6.35M derived: sum of 2 quarters · filed 2025-06-03 | -$7.46M derived: sum of 3 quarters · filed 2025-06-03 | -$8.84M 20-F · filed 2025-06-03 | |
| 2023-09-30 | -$1.04M 6-K · filed 2025-01-02 | -$2.15M derived: sum of 2 quarters · filed 2025-01-02 | -$3.53M 6-K · filed 2025-01-02 | -$4.87M derived: sum of 4 quarters · filed 2025-06-03 | |
| 2023-06-30 | -$1.11M 6-K · filed 2023-08-14 | -$2.50M 6-K · filed 2023-08-14 | -$3.84M derived: sum of 3 quarters · filed 2025-06-03 | -$5.33M derived: sum of 4 quarters · filed 2025-06-03 | |
| 2023-03-31 | -$1.39M 6-K · filed 2023-05-12 | -$2.73M derived: sum of 2 quarters · filed 2025-06-03 | -$4.22M derived: sum of 3 quarters · filed 2025-06-03 | -$2.88M derived: sum of 4 quarters · filed 2025-06-03 | |
| 2022-12-31 | -$1.34M derived: 20-F 12 month − 6-K 9 month · filed 2025-06-03 | -$2.83M derived: sum of 2 quarters · filed 2025-06-03 | -$1.49M derived: sum of 3 quarters · filed 2025-06-03 | -$6.58M 20-F · filed 2025-06-03 | |
| 2022-09-30 | -$1.49M 6-K · filed 2023-11-15 | -$151.00K derived: sum of 2 quarters · filed 2023-11-15 | -$5.24M 6-K · filed 2023-11-15 | -$8.05M derived: sum of 4 quarters · filed 2024-08-29 | |
| 2022-06-30 | $1.34M 6-K · filed 2023-08-14 | -$3.75M 6-K · filed 2023-08-14 | -$6.56M derived: sum of 3 quarters · filed 2024-08-29 | -$9.85M derived: sum of 4 quarters · filed 2024-08-29 | |
| 2022-03-31 | -$5.09M 6-K · filed 2023-05-12 | -$7.90M derived: sum of 2 quarters · filed 2024-08-29 | -$11.19M derived: sum of 3 quarters · filed 2024-08-29 | -$15.18M derived: sum of 4 quarters · filed 2024-08-29 | |
| 2021-12-31 | -$2.81M derived: 20-F 12 month − 6-K/A 9 month · filed 2024-08-29 | -$6.11M derived: sum of 2 quarters · filed 2024-08-29 | -$10.10M derived: sum of 3 quarters · filed 2024-08-29 | -$12.54M 20-F · filed 2024-08-29 | -$33.00K 20-F · filed 2022-03-30 |
| 2021-09-30 | -$3.30M 6-K/A · filed 2022-11-16 | -$7.29M derived: sum of 2 quarters · filed 2022-11-16 | -$9.73M 6-K/A · filed 2022-11-16 | -$11.75M derived: sum of 4 quarters · filed 2023-05-02 | |
| 2021-06-30 | -$3.99M 6-K · filed 2022-08-15 | -$6.43M 6-K · filed 2022-08-15 | -$8.46M derived: sum of 3 quarters · filed 2023-05-02 | -$12.61M derived: sum of 4 quarters · filed 2023-05-02 | |
| 2021-03-31 | -$2.44M 6-K · filed 2022-05-13 | -$4.47M derived: sum of 2 quarters · filed 2023-05-02 | -$8.62M derived: sum of 3 quarters · filed 2023-05-02 | -$11.56M derived: sum of 4 quarters · filed 2023-05-02 | |
| 2020-12-31 | -$2.03M derived: 20-F 12 month − 6-K 9 month · filed 2023-05-02 | -$6.18M derived: sum of 2 quarters · filed 2023-05-02 | -$9.12M derived: sum of 3 quarters · filed 2023-05-02 | -$11.74M 20-F · filed 2023-05-02 | -$18.00K 20-F · filed 2021-03-29 |
| 2020-09-30 | -$4.16M 6-K · filed 2021-11-12 | -$7.10M derived: sum of 2 quarters · filed 2021-11-12 | -$9.71M 6-K · filed 2021-11-12 | ||
| 2020-06-30 | -$2.94M 6-K · filed 2021-08-13 | -$5.55M 6-K · filed 2021-08-13 | |||
| 2020-03-31 | -$2.62M 6-K · filed 2021-05-14 | ||||
| 2019-12-31 | -$163.00K 20-F · filed 2022-03-30 | $163.00K 20-F · filed 2020-03-30 | |||
| 2019-06-30 | -$5.14M 6-K · filed 2020-08-14 | -$8.01M 6-K · filed 2020-08-14 | -$10.73M derived: sum of 3 quarters · filed 2021-03-29 | -$13.53M derived: sum of 4 quarters · filed 2021-03-29 | |
| 2019-03-31 | -$2.87M 6-K · filed 2020-05-14 | -$5.59M derived: sum of 2 quarters · filed 2021-03-29 | -$8.38M derived: sum of 3 quarters · filed 2021-03-29 | -$10.80M derived: sum of 4 quarters · filed 2021-03-29 | |
| 2018-12-31 | -$2.72M derived: 20-F 12 month − 6-K 9 month · filed 2021-03-29 | -$5.51M derived: sum of 2 quarters · filed 2021-03-29 | -$7.93M derived: sum of 3 quarters · filed 2021-03-29 | -$10.59M 20-F · filed 2021-03-29 | |
| 2018-09-30 | -$2.79M 6-K · filed 2018-11-13 | -$5.21M derived: sum of 2 quarters · filed 2019-08-14 | -$7.87M 6-K · filed 2018-11-13 | -$11.20M derived: sum of 4 quarters · filed 2020-03-30 | |
| 2018-06-30 | -$2.42M 6-K · filed 2019-08-14 | -$5.08M 6-K · filed 2019-08-14 | -$8.41M derived: sum of 3 quarters · filed 2020-03-30 | -$12.99M derived: sum of 4 quarters · filed 2020-03-30 | |
| 2018-03-31 | -$2.66M 6-K · filed 2019-05-15 | -$5.99M derived: sum of 2 quarters · filed 2020-03-30 | -$10.57M derived: sum of 3 quarters · filed 2020-03-30 | -$13.28M derived: sum of 4 quarters · filed 2020-03-30 | |
| 2017-12-31 | -$3.33M derived: 20-F 12 month − 6-K 9 month · filed 2020-03-30 | -$7.91M derived: sum of 2 quarters · filed 2020-03-30 | -$10.62M derived: sum of 3 quarters · filed 2020-03-30 | -$13.43M 20-F · filed 2020-03-30 | |
| 2017-09-30 | -$4.58M 6-K · filed 2018-11-13 | -$7.29M derived: sum of 2 quarters · filed 2018-11-13 | -$10.10M 6-K · filed 2018-11-13 | ||
| 2017-06-30 | -$2.71M 6-K · filed 2018-08-13 | -$5.52M 6-K · filed 2018-08-13 | |||
| 2017-03-31 | -$2.66M 6-K · filed 2018-05-15 | ||||
| 2016-12-31 | -$13.11M 20-F · filed 2019-03-29 | ||||
| 2015-12-31 | -$17.89M 20-F · filed 2018-03-30 |